0001251769-22-000085.txt : 20221104
0001251769-22-000085.hdr.sgml : 20221104
20221104182221
ACCESSION NUMBER: 0001251769-22-000085
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221104
FILED AS OF DATE: 20221104
DATE AS OF CHANGE: 20221104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Black Jeffrey G.
CENTRAL INDEX KEY: 0001449439
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35706
FILM NUMBER: 221363373
MAIL ADDRESS:
STREET 1: 4955 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apollo Endosurgery, Inc.
CENTRAL INDEX KEY: 0001251769
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 161630142
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1120 SOUTH CAPITAL OF TX HWY
STREET 2: BUILDING 1 SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 512-279-5100
MAIL ADDRESS:
STREET 1: 1120 SOUTH CAPITAL OF TX HWY
STREET 2: BUILDING 1 SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: LPATH, INC
DATE OF NAME CHANGE: 20060316
FORMER COMPANY:
FORMER CONFORMED NAME: LPATH INC
DATE OF NAME CHANGE: 20051202
FORMER COMPANY:
FORMER CONFORMED NAME: NEIGHBORHOOD CONNECTIONS INC
DATE OF NAME CHANGE: 20040323
4
1
wf-form4_166760052642987.xml
FORM 4
X0306
4
2022-11-04
0
0001251769
Apollo Endosurgery, Inc.
APEN
0001449439
Black Jeffrey G.
1120 S. CAPITAL OF TEXAS HIGHWAY
BUILDING ONE, SUITE 300
AUSTIN
TX
78746
0
1
0
0
Chief Financial Officer
Common Stock
2022-11-04
4
F
0
15060
6.46
D
332650
D
This transaction is not a sale of shares by the Reporting Person in the open market. Instead, this represents shares that have been withheld by the Issuer to satisfy the Reporting Person's income tax and withholding obligation in connection with the vesting of the first tranche of previously reported performance-based vesting restricted stock units reported on the Form 4 dated August 11, 2021. This net settlement was approved by the Issuer's compensation committee.
/s/ Brian Szymczak - Attorney-in-Fact
2022-11-04